Alpine Immune Sciences, Inc. reported raising $10.3 Million in an initial SEC Form D filing, from an offering of $48 Million
Amount Raised
$10.3 Million
$10.3 Million sold, per SEC Form D (first sale Jun 21, 2016)
SeattleBiotechnologyWho to call at Alpine Immune Sciences, Inc., and when
A new round usually means Alpine Immune Sciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alpine Immune Sciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alpine Immune Sciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alpine Immune Sciences, Inc.. With Fundz connected, it knows.
Watch Fundz in Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★ 4.8/5 on G2
Company
Alpine Immune Sciences, Inc.
Location
600 STEWART ST.
Seattle, Washington, United States
About
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alpine Immune Sciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Alpine Immune Sciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
